A new finding by Stanford researchers represents a missing link between two worlds — that of dietary science, and that of molecular and cellular biology.
Weissman and Johns Hopkins’ Bert Vogelstein will share the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for discoveries in stem cell and cancer biology.
If the antibody treatment is eventually found to be viable in humans, it could increase the numbers of people who benefit from hematopoietic stem transplants, Stanford researchers said.
Researchers at Stanford and the University of Tokyo may have cracked the code to doing stem cell transplants and gene therapy without radiation and chemotherapy.
In preclinical trials, Stanford scientists and their collaborators harnessed the gene-editing system CRISPR-Cas9 to replace the mutated gene underpinning the devastating immune disease.
Video: Viral DNA is crucial to human development
REMS seminars will resume after summer